Who are Benitec Biopharma Inc.'s major customers?

Benitec Biopharma Inc. (BNTC) key customers include: Myriad Genetics, Inc., Myriad Genetics, Inc., AUSTRALIA-BENITEC-AUSTRALIA-PROPRIETARY-LIMITED-, LIFE-TECHNOLOGIES-CORP, PROPRIETARY-LIMITED. View the full customer network at chainsifter.com/chain/BNTC.

What sector is Benitec Biopharma Inc. in?

Benitec Biopharma Inc. (BNTC) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Benitec Biopharma Inc. (BNTC) Suppliers & Customers

0Suppliers

5Customers

2Debt Items

20Related Chains

Source-Backed Evidence Depth

Benitec Biopharma Inc. (BNTC) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

8Total relationships

1Distinct source URLs

3High confidence

0.750Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Benitec Biopharma Inc. Suppliers

No suppliers on recordBenitec Biopharma Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Benitec Biopharma Inc. Customers

Ticker	Name	Confidence	Evidence
MYGN	Myriad Genetics, Inc.	72%	Reciprocal relationship from MYGN graph: Reciprocal relationship from BNTC graph: vestigators, CROs, consultants and vendors may engage in misconduct or other improper activities, including noncompli…
MYGN	Myriad Genetics, Inc.	72%	vestigators, CROs, consultants and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and insider trading. We are exposed to the risk of …
AUSTRALIA-BENITEC-AUSTRALIA-PROPRIETARY-LIMITED-	AUSTRALIA-BENITEC-AUSTRALIA-PROPRIETARY-LIMITED-	62%	4,464 Liabilities and Stockholders’ Equity Current liabilities: Trade and other payables $ 4,165 $ 3,231 Accrued employee benefits 475 472 Lease liabilities, current portion 284 275 Total current lia…
LIFE-TECHNOLOGIES-CORP	LIFE-TECHNOLOGIES-CORP	62%	vestigators, CROs, consultants and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and insider trading. We are exposed to the risk of …
PROPRIETARY-LIMITED	PROPRIETARY-LIMITED	62%	4,464 Liabilities and Stockholders’ Equity Current liabilities: Trade and other payables $ 4,165 $ 3,231 Accrued employee benefits 475 472 Lease liabilities, current portion 284 275 Total current lia…

Benitec Biopharma Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
BNTC-DEBT	Debt stack $876,000	90%	Market cache reports total debt of $876,000.
BNTC-DEBT-8312	Warrants outstanding: 2584239	90%	xbrl warrant detail from xbrl 2024-04-22.

Benitec Biopharma Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Benitec Biopharma Inc..

Benitec Biopharma Inc. Ownership

Holder	Name	Confidence	Evidence
BNTC-OWNER-SUVRETTA-CAPITAL-MANAGEMENT-LLC	SUVRETTA CAPITAL MANAGEMENT, LLC	90%	13F overlay lists SUVRETTA CAPITAL MANAGEMENT, LLC as top holder; 88 tracked holders.

Benitec Biopharma Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
DNLI	Denali Therapeutics Inc.	100.00	2
JANX	Janux Therapeutics, Inc.	100.00	2
BIOA	BioAge Labs, Inc.	100.00	2
TEM	Tempus AI, Inc.	100.00	2
CALC	CalciMedica, Inc.	100.00	2
BNBX	BNB Plus Corp.	100.00	2
DSGN	Design Therapeutics, Inc.	100.00	2
SDGR	Schrödinger, Inc.	100.00	2
CABA	Cabaletta Bio, Inc.	100.00	2
PSNL	Personalis, Inc.	100.00	2
ELVN	Enliven Therapeutics, Inc.	100.00	2
ATYR	aTyr Pharma, Inc.	100.00	2
BIAF	bioAffinity Technologies, Inc.	100.00	2
ALLO	Allogene Therapeutics, Inc.	100.00	2
IMNM	Immunome, Inc.	100.00	2
HOWL	Werewolf Therapeutics, Inc.	100.00	2
TPST	Tempest Therapeutics, Inc.	100.00	2
GH	Guardant Health, Inc.	100.00	2
KDK	Kodiak AI, Inc.	100.00	2
IRD	Opus Genetics, Inc.	100.00	2

Benitec Biopharma Inc. Supply Chain